Navigation Links
XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market
Date:10/16/2008

sted on Alternext/NYSE-Euronext Paris since Sept. 18th 2006. Code ISIN: FR0004155612, mnemonic ALXIR.

More information:

http://www.xiring.com

http://www.remotecardauthentication.info

http://www.homechipandpin.co.uk


'/>"/>
SOURCE SCM Microsystems; XIRING
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Agfa HealthCare, InterComponentWare, and Sun Microsystems Join Open eHealth Foundation at HIMSS08
2. e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification
3. CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems
4. 3rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide, Inc.
5. Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd.
6. PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File
7. Perth Leadership Institute Issues Alert on the Post-Crash Environment Facing HR/Leadership Development
8. Children as Young as 4 Can Develop OCD
9. HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device
10. 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program
11. CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 2Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 4Health News:LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees 2Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 2Health News:Al Copeland Foundation Signs on as Title Sponsor of 2009 Chris Paul Basketball Camp 3Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 2Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 3Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 4Health News:Thomson Reuters Announces 100 Top Hospitals Award Winners 5Health News:A Star-Filled Evening with The AFA's Illuminations Los Angeles 2Health News:A Star-Filled Evening with The AFA's Illuminations Los Angeles 3Health News:Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record 2
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 1HealthFitness Announces Third Quarter 2009 Financial Results 60712 2HealthFitness Announces Third Quarter 2009 Financial Results 60712 3HealthFitness Announces Third Quarter 2009 Financial Results 60712 4HealthFitness Announces Third Quarter 2009 Financial Results 60712 5HealthFitness Announces Third Quarter 2009 Financial Results 60712 6HealthFitness Announces Third Quarter 2009 Financial Results 60712 7HealthFitness Announces Third Quarter 2009 Financial Results 60712 8HealthFitness Announces Third Quarter 2009 Financial Results 60712 9HealthFitness Announces Third Quarter 2009 Financial Results 60712 10HealthFitness Announces Third Quarter 2009 Financial Results 60712 11Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 1Zyngenia Inc Raises 2410 Million in Series A Funding 14724 2Zyngenia Inc Raises 2410 Million in Series A Funding 14724 3Zyngenia Inc Raises 2410 Million in Series A Funding 14724 4